Fabio Benedetti

8.5k total citations
164 papers, 3.1k citations indexed

About

Fabio Benedetti is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Fabio Benedetti has authored 164 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 48 papers in Oncology and 42 papers in Organic Chemistry. Recurrent topics in Fabio Benedetti's work include Lymphoma Diagnosis and Treatment (26 papers), Chemical Synthesis and Analysis (25 papers) and HIV/AIDS drug development and treatment (16 papers). Fabio Benedetti is often cited by papers focused on Lymphoma Diagnosis and Treatment (26 papers), Chemical Synthesis and Analysis (25 papers) and HIV/AIDS drug development and treatment (16 papers). Fabio Benedetti collaborates with scholars based in Italy, United States and Japan. Fabio Benedetti's co-authors include Federico Berti, Stefano Norbedo, Paolo Corradini, Giovanni Pizzolo, Corrado Tarella, Alessandro Rambaldi, Anna Dodero, Fabrizio Vinante, Marco Chilosi and Francesca Patriarca and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Fabio Benedetti

156 papers receiving 3.0k citations

Peers

Countries citing papers authored by Fabio Benedetti

Since Specialization

Citations

This map shows the geographic impact of Fabio Benedetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Benedetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Benedetti more than expected).

Fields of papers citing papers by Fabio Benedetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Benedetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Benedetti. The network helps show where Fabio Benedetti may publish in the future.

Co-authorship network of co-authors of Fabio Benedetti

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Benedetti. A scholar is included among the top collaborators of Fabio Benedetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Benedetti. Fabio Benedetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhancing Proteotoxic Stress in Leiomyosarcoma Cells Triggers Mitochondrial Dysfunctions, Cell Death, and Antitumor Activity in vivo 2021 ·Molecular Cancer Therapeutics ·(unknown), Sara Drioli, Ymera Pignochino, (unknown), (unknown), Francesca D’Este, Raffaella Picco, Emiliano Dalla, G Giordano, Giovanni Grignani, Eros Di Giorgio, Fabio Benedetti, Fulvia Felluga, Claudio Brancolini	5
2	One Pot Synthesis of Micromolar BACE-1 Inhibitors Based on the Dihydropyrimidinone Scaffold and Their Thia and Imino Analogues 2020 ·Molecules ·(unknown), Fabio Benedetti, Federico Berti, (unknown), Sara Drioli, Maria Funicello, (unknown), (unknown), Fulvia Felluga	17
3	Synthesis and biological evaluation in vitro and in mammalian cells of new heteroaryl carboxyamides as HIV-protease inhibitors 2017 ·Bioorganic & Medicinal Chemistry ·Maria Funicello, Lucia Chiummiento, (unknown), Maria Francesca Armentano, Faustino Bisaccia, (unknown), Luigi Milella, Fabio Benedetti, Federico Berti, Paolo Lupattelli	8
4	Clinical and Experimental Efficacy of Gemtuzumab Ozogamicin in Core Binding Factor Acute Myeloid Leukemia 2017 ·Hematology Reports ·Michele Gottardi, Federico Mosna, Sergio Angeli, Cristina Papayannidis, Anna Candoni, Marino Clavio, Cristina Tecchio, Andrea Piccin, Marta Dell’Orto, Fabio Benedetti, Giovanni Martinelli, Filíppo Gherlinzoni	15
5	Synthesis of Chiral, Enantiopure Allylic Amines by the Julia Olefination of α-Amino Esters 2016 ·Molecules ·Fabio Benedetti, Federico Berti, Lidia Fanfoni, (unknown), (unknown), Fulvia Felluga	3
6	RECOURSE trial: Performance status at discontinuation in patients receiving trifluridine/tipiracil (TAS-102) 2016 ·Annals of Oncology ·E. Van Cutsem, Rocio García‐Carbonero, Alessandro Pastorino, Alberto Zaniboni, Alfredo Falcone, Nadia Amellal, Fabio Benedetti, Robert J. Mayer, Atsushi Ohtsu, Josep Tabernero	4
7	Fluorescent molecularly imprinted nanogels for the detection of anticancer drugs in human plasma 2016 ·Biosensors and Bioelectronics ·(unknown), (unknown), Elena Marangon, Flavio Rizzolio, (unknown), Fabio Benedetti, Giuseppe Toffoli, Marina Resmini, Federico Berti	17
8	The Local Complement Activation on Vascular Bed of Patients with Systemic Sclerosis: A Hypothesis-Generating Study 2015 ·PLoS ONE ·(unknown), (unknown), T. Sakari Jokiranta, Lucia De Franceschi, Oscar Bortolami, Valentina La Verde, Patrizia Guarini, Paola Caramaschi, Viviana Ravagnani, Guido Martignoni, Chiara Colato, Serena Pedron, Fabio Benedetti, (unknown), (unknown), Domenico Biasi	27
9	Designing Short Peptides with High Affinity for Organic Molecules: A Combined Docking, Molecular Dynamics and Monte Carlo Approach 2013 ·Biophysical Journal ·(unknown), Silvia Pavan, Fabio Benedetti, Alessandro Tossi, (unknown), Federico Berti, Alessandro Laio	15
10	Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect 2011 ·Leukemia ·Anna Dodero, Francesco Spina, Franco Narni, Francesca Patriarca, Irene Cavattoni, Fabio Benedetti, Fabio Ciceri, D Baronciani, Rosanna Scimè, Enrico Pogliani, Alessandro Rambaldi, Francesca Bonifazi, (unknown), Benedetto Bruno, Paolo Corradini	94
11	Amphotericin B Lipid Complex in the Management of Invasive Fungal Infections in Immunocompromised Patients 2011 ·Clinical Drug Investigation ·Matteo Bassetti, Franco Aversa, Filippo Ballerini, Fabio Benedetti, Alessandro Busca, Nicola Cascavilla, Ercole Concia, Andrea Tendas, Francesco Di Raimondo, Patrizio Mazza, Anna Maria Nosari, Giuseppe Rossi	12
12	Clinical, Serologic and Instrumental Data of Ten Patients Affected by Sclerodermatous Chronic Graft versus Host Disease: Similarities and Differences in Respect to Systemic Sclerosis 2010 ·International Journal of Immunopathology and Pharmacology ·Giovanni Barausse, Paola Caramaschi, (unknown), Fabio Benedetti, (unknown), (unknown), Ilaria Tinazzi, L. Benini, Lisa Maria Bambara, Domenico Biasi	13
13	Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing –PheΨPro– core and displaying favourable ADME-related properties 2008 ·Journal of Molecular Graphics and Modelling ·Vladimı́r Frecer, Federico Berti, Fabio Benedetti, Stanislav Miertuš	35
14	Small hydroxyethylene-based peptidomimetics inhibiting both HIV-1 and C. albicans aspartic proteases 2003 ·Bioorganic & Medicinal Chemistry ·Alessandro Tossi, Fabio Benedetti, Stefano Norbedo, (unknown), Federico Berti, Domenico Romeo	18
15	Albumin-controlled stereoselective reduction of 1,3-diketones to anti-diolsElectronic supplementary information (ESI) available: Scatchard and Lineweaver–Burk plots. See http://www.rsc.org/suppdata/cc/b2/b200474g/ 2002 ·Chemical Communications ·Fabio Benedetti, Federico Berti, Ivan Donati, (unknown)	17
16	Intensification of salvage treatment with high‐dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non‐Hodgkin's lymphoma 2001 ·British Journal of Haematology ·Sergio Cortelazzo, Alessandro Rambaldi, Andrea Rossi, Elena Oldani, Michele Ghielmini, Fabio Benedetti, Corrado Tarella, (unknown), Umberto Vitolo, Massimo Di Nicola, Enrico Pogliani, F. Cavalli, Alessandro M. Gianni, Tiziano Barbui	29
17	Computational Design of New Cyclic Urea Inhibitors for Improved Binding of HIV-1 Aspartic Protease 2000 ·Biochemical and Biophysical Research Communications ·K. Bhanuprakash, (unknown), Fabio Benedetti, Stanislav Miertuš	3
18	Flexible synthesis of symmetric and non-symmetric hiv-1 protease inhibitors based on all-s-diaminodiol isosteres 1999 ·ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) ·Alessandro Tossi, Nikolinka Antcheva, Fabio Benedetti, (unknown), Stanislav Miertuš, (unknown)	1
19	Abnormalities of Pulmonary Function Tests After Marrow Transplantation Predict Nonrelapse Mortality 1995 ·American Journal of Respiratory and Critical Care Medicine ·S W Crawford, M. S. Pepe, Daniel J. Lin, Fabio Benedetti, H. Joachim Deeg	38
20	Reactivity of secondary functionalized enamines towards electrophilic diazenes. 1991 ·ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) ·Fabio Benedetti, (unknown), (unknown), (unknown), (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact